The Cooper Companies, Inc. (COO) Return on Equity (ROE): 2.86%
Is The Cooper Companies, Inc.’s return on equity (ROE) high or low?
The Cooper Companies, Inc.'s return on equity (ROE) of 2.86% is 75% below its 5-year average of 11.22%, near the low end of its 5-year range (2.86%–42.42%).
As of Sunday, June 14, 2026. 39.15% below its 12-month average of 4.70%.
COO Return on Equity (ROE) Chart
COO Average Return on Equity (ROE) Chart
COO Current vs Average Return on Equity (ROE) Chart
COO Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
2.86%
RETURN ON EQUITY (ROE) AVG TTM
4.70%
RETURN ON EQUITY (ROE) AVG 3Y
4.67%
RETURN ON EQUITY (ROE) AVG 5Y
11.22%
RETURN ON EQUITY (ROE) AVG 10Y
10.36%
RETURN ON EQUITY (ROE) AVG 15Y
10.25%
RETURN ON EQUITY (ROE) AVG 20Y
8.87%
CURRENT VS TTM AVG
-39.15%
CURRENT VS 3Y AVG
-38.76%
CURRENT VS 5Y AVG
-74.51%
CURRENT VS 10Y AVG
-72.39%
CURRENT VS 15Y AVG
-72.08%
CURRENT VS 20Y AVG
-67.76%
COO Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 2.86% | 4.70% | 4.67% | 11.22% |
| Solventum Corporation (SOLV) | $13.66B | 28.82% | 23.51% | 17.50% | 13.68% |
| Align Technology, Inc. (ALGN) | $12.52B | 10.36% | 10.54% | 10.84% | 19.93% |
| Baxter International Inc. (BAX) | $10.77B | -18.17% | -12.46% | -8.76% | -1.37% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Hologic, Inc. (HOLX) | $16.97B | 10.37% | 13.30% | 15.60% | 24.66% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | -6.28% | -2.13% | 6.32% | 9.65% |
| Tempus AI, Inc. (TEM) | $8.35B | -72.74% | -651.33% | -315.37% | -198.08% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 2.46% | -8.94% | -15.72% | 1.14% |
| Moderna, Inc. (MRNA) | $19.80B | -43.12% | -32.64% | -13.90% | 0.25% |
Return Analysis
ROE
2.9%
ROA
1.9%
The Cooper Companies, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The return on equity (ROE) for COO stock is 2.86%.
- Is The Cooper Companies, Inc.'s return on equity (ROE) high or low?
- The Cooper Companies, Inc.'s return on equity (ROE) of 2.86% is 75% below its 5-year average of 11.22%, near the low end of its 5-year range (2.86%–42.42%).
- What is the TTM average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The TTM average return on equity (ROE) for COO stock is 4.70%.
- What is the 3Y average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The 3Y average return on equity (ROE) for COO stock is 4.67%.
- What is the 5Y average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The 5Y average return on equity (ROE) for COO stock is 11.22%.
- What is the 10Y average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The 10Y average return on equity (ROE) for COO stock is 10.36%.
- What is the 15Y average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The 15Y average return on equity (ROE) for COO stock is 10.25%.
- What is the 20Y average return on equity (ROE) for The Cooper Companies, Inc. (COO)?
- The 20Y average return on equity (ROE) for COO stock is 8.87%.
The Cooper Companies, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-10-31 | 4.55% |
| 2024-10-31 | 4.85% |
| 2023-10-31 | 3.90% |
| 2022-10-31 | 5.38% |
| 2021-10-31 | 42.42% |
| 2020-10-31 | 6.23% |
| 2019-10-31 | 12.86% |
| 2018-10-31 | 4.23% |
| 2017-10-31 | 11.74% |
| 2016-10-31 | 10.16% |
| 2015-10-31 | 7.63% |
| 2014-10-31 | 10.50% |
| 2013-10-31 | 12.32% |
| 2012-10-31 | 11.33% |
| 2011-10-31 | 9.05% |
| 2010-10-31 | 6.77% |
| 2009-10-31 | 6.53% |
| 2008-10-31 | 4.62% |
| 2007-10-31 | -0.77% |
| 2006-10-31 | 4.80% |
| 2005-10-31 | 7.20% |
| 2004-10-31 | 17.06% |
| 2003-10-31 | 16.29% |
| 2002-10-31 | 15.69% |
| 2001-10-31 | 14.49% |
| 2000-10-31 | 14.60% |
| 1999-10-31 | 15.30% |
| 1998-10-31 | 27.39% |
| 1997-10-31 | 28.16% |
| 1996-10-31 | 108.50% |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White